Predictive genomic and transcriptomic analysis on endoscopic ultrasound-guided fine needle aspiration materials from primary pancreatic adenocarcinoma: a prospective multicentre study
Rémy Nicolle,Cindy Canivet,Laurent Palazzo,Bertrand Napoléon,Mira Ayadi,Camille Pignolet,Jérôme Cros,Sophie Gourgou,Janick Selves,Jérôme Torrisani,Nelson Dusetti,Pierre Cordelier,Louis Buscail,Barbara Bournet,BACAP Consortium,Nicolas Carrère,Fabrice Muscari,Bertrand Suc,Rosine Guimbaud,Corinne Couteau,Marion Deslandres,Pascale Rivera,Emily Alouany,Nadim Fares,Karl Barange,Anne Gomez-Brouchet,Adrian Culetto,Guillaume Le Cosquer,Marion Jaffrelot,Bertrand Pujol,Fabien Fumex,Jérôme Desrame,Christine Lefort,Vincent Lepilliez,Rodica Gincul,Pascal Artru,Léa Clavel,Anne-Isabelle Lemaistre,Sarah Tubiana,Nicolas Flori,Pierre Senesse,Pierre-Emmanuel Colombo,Emmanuelle Samalin-Scalzi,Fabienne Portales,Lise Roca,Claire Honfo Ga,Carinne Plassot,Marc Ychou,Pierre Guibert,Christelle De La Fouchardière,Mathieu Sarabi,Patrice Peyrat,Séverine Tabone-Eglinger,Caroline Renard,Guillaume Piessen,Stéphanie Truant,Alain Saudemont,Guillaume Millet,Florence Renaud,Emmanuelle Leteurtre,Patrick Gelé,Eric Assenat,Jean-Michel Fabre,François-Régis Souche,Marie Dupuy,Anne-Marie Gorce-Dupuy,Jeanne Ramos,Jean-François Seitz,Jean Hardwigsen,Emmanuelle Norguet-Monnereau,Philippe Grandval,Muriel Duluc,Dominique Figarella-Branger,Véronique Vendrely,Clément Subtil,Eric Terrebonne,Jean-Frédéric Blanc,Jean-Philippe Merlio,Dominique Farges-Bancel,Jean-Marc Gornet,Daniela Geromin,Geoffroy Vanbiervliet,Anne-Claire Frin,Delphine Ouvrier,Marie-Christine Saint-Paul,Philippe Berthélémy,Chelbabi Fouad,Stéphane Garcia,Nathalie Lesavre,Mohamed Gasmi,Marc Barthet,Vanessa Cottet,Cyrille Delpierre
DOI: https://doi.org/10.1016/j.ebiom.2024.105373
IF: 11.205
EBioMedicine
Abstract:Background: We apply endoscopic ultrasound-guided fine needle aspiration biopsy to cytopathologically diagnose and sample nucleic acids from primary tumours regardless of the disease stage. Methods: 397 patients with proven pancreatic adenocarcinoma were included and followed up in a multicentre prospective study. DNA and mRNA were extracted from materials of primary tumours obtained by endoscopic ultrasound-guided fine needle aspiration biopsy and analysed using targeted deep sequencing and RNAseq respectively. Findings: The variant allele frequency of the KRAS mutation was used to evaluate the tumour cellularity, ranging from 15 to 20% in all cells, regardless of the tumour stage. The molecular profile of metastatic primary tumours significantly differed from other types of tumours, more frequently having TP53 mutations (p = 0.0002), less frequently having RNF43 mutations, and possessing more basal-like mRNA component (p = 0.001). Molecular markers associated with improved overall survival were: mutations in homologous recombination deficiency genes in patients who received first-line platinum-based chemotherapy (p = 0.025) and wild-type TP53 gene in patients with locally advanced tumours who received radio-chemotherapy (p = 0.01). The GemPred transcriptomic profile was associated with a significantly better overall survival in patients with locally advanced or metastatic pancreatic cancer who received a gemcitabine-based first-line treatment (p = 0.019). Interpretation: The combination of genomic and transcriptomic analyses of primary pancreatic tumours enables us to distinguish metastatic tumours from other tumour types. Our molecular strategy may assist in predicting overall survival outcomes for platinum or gemcitabine-based chemotherapies, as well as radio-chemotherapy. Funding: Institut National Du Cancer (BCB INCa_7294), CHU of Toulouse, Inserm and Ligue Nationale Contre le Cancer (CIT program).